Coherus BioSciences, Inc. (CHRS): A Bull Case Theory

We came across a bullish thesis on Coherus BioSciences, Inc. (CHRS) on Steve Wagner’s Substack. In this article, we will summarize the bulls’ thesis on CHRS. Coherus BioSciences, Inc. (CHRS)'s share was trading at $0.77 as of 30^th May. CHRS’s trailing P/E was 1.77 according to Yahoo Finance.

[caption id="attachment_1238483" align="aligncenter" width="768"] Scientist in a lab working on a research project, focusing on biotechnology and healthcare advancements.[/caption]

Coherus BioSciences (CHRS), long overlooked by Wall Street, is taking a bold step into innovative oncology...